The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis

Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM).Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between Nove...

Full description

Bibliographic Details
Main Authors: Jie Xu, Lingjuan Liu, Jie Xiong, Lu Zhang, Peng Huang, Li Tang, Yangyang Xiao, Xingfang Li, Jian Li, Yingying Luo, Huiling Li, Dingan Mao, Liqun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.679430/full
id doaj-ad36662f05954bd6a9df2718aecc5fef
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jie Xu
Jie Xu
Lingjuan Liu
Lingjuan Liu
Jie Xiong
Jie Xiong
Lu Zhang
Lu Zhang
Peng Huang
Peng Huang
Li Tang
Li Tang
Yangyang Xiao
Yangyang Xiao
Xingfang Li
Xingfang Li
Jian Li
Jian Li
Yingying Luo
Huiling Li
Dingan Mao
Dingan Mao
Liqun Liu
Liqun Liu
spellingShingle Jie Xu
Jie Xu
Lingjuan Liu
Lingjuan Liu
Jie Xiong
Jie Xiong
Lu Zhang
Lu Zhang
Peng Huang
Peng Huang
Li Tang
Li Tang
Yangyang Xiao
Yangyang Xiao
Xingfang Li
Xingfang Li
Jian Li
Jian Li
Yingying Luo
Huiling Li
Dingan Mao
Dingan Mao
Liqun Liu
Liqun Liu
The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
Frontiers in Neurology
myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis
demyelinating disease
optic neuritis
pediatrics
adults
author_facet Jie Xu
Jie Xu
Lingjuan Liu
Lingjuan Liu
Jie Xiong
Jie Xiong
Lu Zhang
Lu Zhang
Peng Huang
Peng Huang
Li Tang
Li Tang
Yangyang Xiao
Yangyang Xiao
Xingfang Li
Xingfang Li
Jian Li
Jian Li
Yingying Luo
Huiling Li
Dingan Mao
Dingan Mao
Liqun Liu
Liqun Liu
author_sort Jie Xu
title The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_short The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_full The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_fullStr The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_full_unstemmed The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
title_sort clinical, radiologic, and prognostic differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-05-01
description Purpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM).Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020.Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully.Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better.
topic myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis
demyelinating disease
optic neuritis
pediatrics
adults
url https://www.frontiersin.org/articles/10.3389/fneur.2021.679430/full
work_keys_str_mv AT jiexu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lingjuanliu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lingjuanliu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexiong theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexiong theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luzhang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luzhang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT penghuang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT penghuang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT litang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT litang theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yangyangxiao theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yangyangxiao theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xingfangli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xingfangli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jianli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jianli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yingyingluo theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT huilingli theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT dinganmao theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT dinganmao theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liqunliu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liqunliu theclinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lingjuanliu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT lingjuanliu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexiong clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jiexiong clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luzhang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT luzhang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT penghuang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT penghuang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT litang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT litang clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yangyangxiao clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yangyangxiao clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xingfangli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT xingfangli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jianli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT jianli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT yingyingluo clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT huilingli clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT dinganmao clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT dinganmao clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liqunliu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
AT liqunliu clinicalradiologicandprognosticdifferencesbetweenpediatricandadultpatientswithmyelinoligodendrocyteglycoproteinantibodyassociatedencephalomyelitis
_version_ 1721435997616472064
spelling doaj-ad36662f05954bd6a9df2718aecc5fef2021-05-20T06:29:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-05-011210.3389/fneur.2021.679430679430The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated EncephalomyelitisJie Xu0Jie Xu1Lingjuan Liu2Lingjuan Liu3Jie Xiong4Jie Xiong5Lu Zhang6Lu Zhang7Peng Huang8Peng Huang9Li Tang10Li Tang11Yangyang Xiao12Yangyang Xiao13Xingfang Li14Xingfang Li15Jian Li16Jian Li17Yingying Luo18Huiling Li19Dingan Mao20Dingan Mao21Liqun Liu22Liqun Liu23Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Neurology, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, ChinaChildren's Brain Development and Brain Injury Research Office, The Second Xiangya Hospital, Central South University, Changsha, ChinaPurpose: To evaluate the clinical differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM).Methods: We retrospectively reviewed the clinical features of pediatric and adult patients with MOG-EM in our center between November 2015 and October 2020.Results: Twenty-eight pediatric patients and 25 adults were admitted to our study. Bilateral optic neuritis (BON) was the most common initial phenotype in the pediatric group but less common in the adult group (28.57 vs. 0%, p = 0.0119). Almost half of the adult patients presented with neuromyelitis optica spectrum disease (NMOSD), which was less prevalent among the pediatrics (48 vs. 21.43%, p = 0.0414). Visual impairment was the most common symptom in both groups during the initial attack (pediatric group, 39.29%; adult group, 64%) and throughout the full course (pediatric group, 57.14%; adult group, 72%). More pediatric patients suffered from fever than adult patients at onset (pediatric group, 28.57%; adult group, 4%; p = 0.0442) and throughout the full course (pediatric group, 39.29%; adult group, 12%; p = 0.0245). Multiple patchy lesions in subcortical white matter (pediatric group, 40.74%; adult group, 45%), periventricular (pediatric group, 25.93%; adult group, 35%), infratentorial (pediatric group, 18.52%; adult group, 30%) and deep gray matter (pediatric group, 25.93%; adult group, 20%) were frequent in all cases, no significant difference was found between the two groups, while bilateral optic nerve involvement was more frequent in pediatric group (61.54 vs. 14.29%, p = 0.0042) and unilateral optic nerve involvement was higher in adult group (64.29 vs. 15.38%, p = 0.0052). At the last follow-up, adult patients had a higher average EDSS score (median 1.0, range 0–3) than pediatrics (median 0.0, range 0–3), though not significant (p = 0.0752). Patients aged 0–9 years (61.54%) and 10–18 years (70%), and patients presenting with encephalitis/meningoencephalitis (100%) and ADEM (75%) were more likely to recover fully.Conclusions: Visual impairment was the dominant symptom in both pediatric and adult patients, while fever was more frequent in pediatric patients. Data suggested that BON and bilateral optic nerve involvement were more common in pediatric cases whereas NMOSD and unilateral optic nerve involvement were more prevalent in adults. The younger patients and patients presenting with encephalitis/meningoencephalitis and ADEM tended to recover better.https://www.frontiersin.org/articles/10.3389/fneur.2021.679430/fullmyelin oligodendrocyte glycoprotein antibody-associated encephalomyelitisdemyelinating diseaseoptic neuritispediatricsadults